News
Medpage Today on MSN10h
Subcutaneous Lecanemab Maintenance Dosing for Alzheimer's Supported by New Data
TORONTO -- An investigational subcutaneous autoinjector showed comparable efficacy and safety to the IV formulation of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback